BEAM
BEAM
NASDAQ · Biotechnology

Beam Therapeutics Inc

$24.95
+0.28 (+1.14%)
As of Sep 20, 10:03 PM ET ·
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 20 87%
Hold 3 13%
Sell 0 0%
Price Target
Analyst Price Target +148.8% upside
Low Target $37.88
Average Target $62.07
High Target $80.69
Current Price $24.95
Current
$24.95
Target
$62.07
$37.88 $62.07 avg $80.69
Scenario Analysis
Bear Case
$37.88
51.8%
Low target
Base Case
$62.07
+148.8%
Avg target
Bull Case
$80.69
+223.4%
High target
Risk/Reward
4.3x
Highly favorable
Price in Context
52-Week High
$38.26
-34.8% from high
52-Week Low
$20.23
+23.3% from low
50-Day SMA
$28.48
-12.4% vs SMA
200-Day SMA
$22.69
+10.0% vs SMA
RSI (14)
44.0
Neutral
Target vs 52W High
$62.07
+62.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%